You guys sound like that knight that lost all of his arms and legs in Monty Python - I'm sorry - but I think PXS holders need to come to grips with the reality of what this means. It is a terrible outcome, and will cost time and money for big salaries. The IP has a limited lifespan. The US is the market all pharma companies need to get big margins.
I'm no longer short this co, but am thinking about shorting it again.
response letter, page-4
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.13M | |||
| Open | High | Low | Value | Volume |
| 2.9¢ | 3.0¢ | 2.8¢ | $145.4K | 5.129M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 1763138 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 235590 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| SNT (ASX) Chart |